Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020

SELL
$69.39 - $97.59 $305,316 - $429,396
-4,400 Closed
0 $0
Q3 2019

Nov 01, 2019

SELL
$64.17 - $84.08 $19,251 - $25,224
-300 Reduced 6.38%
4,400 $312,000
Q2 2019

Aug 02, 2019

BUY
$70.1 - $85.17 $14,019 - $17,034
200 Added 4.44%
4,700 $400,000
Q1 2019

May 02, 2019

SELL
$77.0 - $99.34 $7,700 - $9,934
-100 Reduced 2.17%
4,500 $383,000
Q4 2018

Jan 30, 2019

BUY
$83.85 - $110.34 $16,770 - $22,068
200 Added 4.55%
4,600 $396,000
Q3 2018

Nov 02, 2018

BUY
$97.14 - $113.31 $19,428 - $22,662
200 Added 4.76%
4,400 $499,000
Q2 2018

Aug 10, 2018

BUY
$74.5 - $108.91 $14,900 - $21,782
200 Added 5.0%
4,200 $436,000
Q3 2017

Nov 01, 2017

BUY
$84.87 - $109.54 $339,480 - $438,160
4,000
4,000 $352,000

Others Institutions Holding HSKA

About HESKA CORP


  • Ticker HSKA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 10,818,900
  • Description
  • Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and ...
More about HSKA
Track This Portfolio

Track Gabelli Funds LLC Portfolio

Follow Gabelli Funds LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gabelli Funds LLC with notifications on news.